The Importance of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19

被引：2
|
作者：
Schlom, Jeffrey [1 ]
Donahue, Renee N. [1 ]
机构：
[1] NCI, Lab Tumor Immunol & Biol, Ctr Canc Res, NIH, 10 Ctr Dr,Room 8B09, Bethesda, MD 20892 USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2020年 / 222卷 / 09期
基金：
美国国家卫生研究院;
关键词：
COVID-19; SARS-CoV-2; T-cell immunity; vaccines; immunology; human immunome; PHASE-I;
D O I：
10.1093/infdis/jiaa415
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
It is important to develop vaccines that can also mediate T-cell responses to SARS-CoV-2 to limit severity of infections, and to analyze the cellular immunome in the use of anti-SARS-CoV-2 therapeutics.
引用
收藏
页码：1435 / 1438
页数：4
相关论文
共 50 条
  • [1] COVID-19: Vaccines and therapeutics
    Ponnampalli, Swapna
    Birudukota, Naga Venkata Suryanarayana
    Kamal, Ahmed
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 75
  • [2] Current development of COVID-19 diagnostics, vaccines and therapeutics
    Zhang, Naru
    Li, Chaoqun
    Hu, Yue
    Li, Kangchen
    Liang, Jintian
    Wang, Lili
    Du, Lanying
    Jiang, Shibo
    MICROBES AND INFECTION, 2020, 22 (6-7) : 231 - 235
  • [3] Discovery and development of COVID-19 vaccines and therapeutics: nonclinical perspectives
    Khan, Nasir
    Sathish, Jean
    Rohde, Cynthia M.
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2024, 49 (03): : 79 - 94
  • [4] Covid-19 vaccines, immunity, and boosters
    Richterman, Aaron
    Scott, Jake
    Cevik, Muge
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 375
  • [5] Boosting immunity to COVID-19 vaccines
    Juno, Jennifer A.
    Wheatley, Adam K.
    NATURE MEDICINE, 2021, 27 (11) : 1874 - 1875
  • [6] Boosting immunity to COVID-19 vaccines
    Jennifer A. Juno
    Adam K. Wheatley
    Nature Medicine, 2021, 27 : 1874 - 1875
  • [7] Multi-omics for COVID-19:driving development of therapeutics and vaccines
    Mengyu Guo
    Muya Xiong
    Jinying Peng
    Tong Guan
    Haixia Su
    Yanyi Huang
    Cai-Guang Yang
    Yang Li
    Diana Boraschi
    Thanigaimalai Pillaiyar
    Guanbo Wang
    Chengqi Yi
    Yechun Xu
    Chunying Chen
    NationalScienceReview, 2023, 10 (09) : 307 - 336
  • [8] Multi-omics for COVID-19: driving development of therapeutics and vaccines
    Guo, Mengyu
    Xiong, Muya
    Peng, Jinying
    Guan, Tong
    Su, Haixia
    Huang, Yanyi
    Yang, Cai-Guang
    Li, Yang
    Boraschi, Diana
    Pillaiyar, Thanigaimalai
    Wang, Guanbo
    Yi, Chengqi
    Xu, Yechun
    Chen, Chunying
    NATIONAL SCIENCE REVIEW, 2023, 10 (09)
  • [9] Vaccines and therapeutics for immunocompromised patients with COVID-19
    Shoham, Shmuel
    Batista, Carolina
    Ben Amor, Yanis
    Ergonul, Onder
    Hassanain, Mazen
    Hotez, Peter
    Kang, Gagandeep
    Kim, Jerome H.
    Lall, Bhavna
    Larson, Heidi J.
    Naniche, Denise
    Sheahan, Timothy
    Strub-Wourgaft, Nathalie
    Sow, Samba O.
    Wilder-Smith, Annelies
    Yadav, Prashant
    Bottazzi, Maria Elena
    ECLINICALMEDICINE, 2023, 59
  • [10] The Equitable Distribution of COVID-19 Therapeutics and Vaccines
    Bollyky, Thomas J.
    Gostin, Lawrence O.
    Hamburg, Margaret A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (24): : 2462 - 2463
12345